BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24119542)

  • 1. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
    Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
    Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous TREM2 mutations in frontotemporal dementia.
    Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
    Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
    Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
    Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
    Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
    Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
    Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
    Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding variants in TREM2 increase risk for Alzheimer's disease.
    Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
    Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.
    Fenoglio C; Galimberti D; Piccio L; Scalabrini D; Panina P; Buonsanti C; Venturelli E; Lovati C; Forloni G; Mariani C; Bresolin N; Scarpini E
    Neurosci Lett; 2007 Jan; 411(2):133-7. PubMed ID: 17088018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients.
    Peplonska B; Berdynski M; Mandecka M; Barczak A; Kuzma-Kozakiewicz M; Barcikowska M; Zekanowski C
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):407-412. PubMed ID: 29557178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 variants in Alzheimer's disease.
    Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
    N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese.
    Jiang T; Tan L; Chen Q; Tan MS; Zhou JS; Zhu XC; Lu H; Wang HF; Zhang YD; Yu JT
    Neurobiol Aging; 2016 Jun; 42():217.e1-3. PubMed ID: 27067662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia.
    Lattante S; Le Ber I; Camuzat A; Dayan S; Godard C; Van Bortel I; De Septenville A; Ciura S; Brice A; Kabashi E;
    Neurobiol Aging; 2013 Oct; 34(10):2443.e1-2. PubMed ID: 23759145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
    Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.